Myriad Genetics, Inc., a leader in molecular diagnostics and personalised medicine, has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier screening and non─invasive prenatal screening for
More From BioPortfolio on "Myriad Genetics to acquire health technology company, Counsyl for $375 million"